Kurse werden geladen...
Prognose
Für dieses Unternehmen liegen uns keine Analysten-Daten vor.
Scoring-Modelle
Für dieses Unternehmen liegen uns bisher keine Scoring-Modelle vor.
Beliebteste Broker
News
- 20.07. - 15:00 Uhr
Top US Marijuana Penny Stocks to Add to Your Watchlist Before August 2024
The U.S. cannabis industry and marijuana stocks are growing rapidly, with a market size expected to reach $41.5 billion by 2025. This growth is driven by increasing legalization and consumer demand. In recent news, several states have moved closer to full legalization, creating new investor opportunities. Marijuana penny stocks, in particular, offer high potential returns. However, they also come with significant risks. As a result, it is crucial to use technical analysis to identify promising stocks. Additionally, proper risk management is essential to mitigate potential losses. By staying informed and strategic, investors can capitalize on the growing cannabis market. » Mehr auf marijuanastocks.com
- 03.07. - 16:59 Uhr
3 Marijuana Stocks To Watch This Week In July
As of mid-2024, investing in marijuana stocks appears promising for heading into 2025 due to several reasons. The cannabis industry continues its rapid development. Much of which is fueled by increasing legalization efforts globally. In addition to the further acceptance of cannabis products beyond traditional forms like dried flower. » Mehr auf marijuanastocks.com
- 23.06. - 14:30 Uhr
Top Marijuana Stocks with the Most Year-to-Date Upside
Investing in the cannabis sector and top marijuana stocks has become increasingly attractive, especially for those seeking high year-to-date upside. The U.S. cannabis industry is experiencing rapid growth, with sales projected to reach $30 billion in 2024. This growth is driven by increasing legalization and acceptance of cannabis products. Recent headlines indicate significant momentum toward federal legalization, which could further boost the market. Investors are particularly interested in companies showing substantial stock performance and promising financials. » Mehr auf marijuanastocks.com
Unternehmenszahlen
(EUR) | März 2024 | |
---|---|---|
Umsatz | 23,37 Mio | 15,21% |
Bruttoeinkommen | 11,27 Mio | 63,01% |
Nettoeinkommen | 3,86 Mio | 43,21% |
EBITDA | 5,60 Mio | 119,34% |
Fundamentaldaten
Metrik | Wert |
---|---|
Marktkapitalisierung | 38,47 Mio € |
Anzahl Aktien | 309,86 Mio |
52 Wochen-Hoch/Tief | 0,27 € - 0,0533 € |
Dividenden | Nein |
Beta | 3,16 |
KGV (PE Ratio) | 2,07 |
KGWV (PEG Ratio) | 0,05 |
KBV (PB Ratio) | 9,04 |
KUV (PS Ratio) | 0,42 |
Unternehmensprofil
Cansortium Inc. produziert und vertreibt über seine Tochtergesellschaften medizinisches Cannabis in den Vereinigten Staaten. Das Unternehmen ist in den Bereichen Anbau, Verarbeitung, Einzelhandel und Vertrieb tätig. Seine medizinischen Cannabisprodukte werden in Form von oralen Tropfen, Kapseln, Zäpfchen, topischen Produkten, Spritzen, getrockneten Blüten, Prerolls, Patronen und Esswaren angeboten. Das Unternehmen bietet seine Produkte unter dem Markennamen Fluent an. Mit Stand vom 20. August 2021 betrieb es 28 Apotheken. Cansortium Inc. wurde im Jahr 2018 gegründet und hat seinen Hauptsitz in Miami, Florida.
Name | CANSORTIUM INC. Aktie |
CEO | Robert Beasley |
Sitz | Miami,
fl USA |
Website | |
Börsengang | 08.01.2021 |
Mitarbeiter | 0 |
Ticker Symbole
Börse | Symbol |
---|---|
Pnk | CNTMF |
Frankfurt | 2WM.F |
Assets entdecken
Shareholder von CANSORTIUM INC. Aktie investieren auch in folgende Assets